Bridgewater Associates - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$873,000
+14.4%
52,412
+1.1%
0.00%
+33.3%
Q2 2022$763,000
-24.6%
51,855
+27.1%
0.00%
-25.0%
Q1 2022$1,012,000
+6.8%
40,787
+38.0%
0.00%
-33.3%
Q4 2021$948,000
-16.0%
29,560
-5.7%
0.01%0.0%
Q3 2021$1,128,00031,3520.01%
Other shareholders
PULMONX CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders